Acadian Clinic PLLC
Acadian Clinic PLLC was paid $2.84M by Medicaid between Apr 2019 and Dec 2024, across 81 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 58% of everything it billed.
ALLEN PARK, MI 48101
Next to other Internal Medicine Physician providers in Michigan
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 2,294 | $38K | |
| 2020 | 5,902 | $168K | |
| 2021 | 10,719 | $433K | |
| 2022 | 18,298 | $674K | |
| 2023 | 22,660 | $870K | |
| 2024incomplete | 20,306 | $662K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 58% | 23,047 | 18,509 | $1.64M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 12% | 4,164 | 4,155 | $333K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 7.2% | 4,909 | 4,623 | $206K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.3% | 1,840 | 1,679 | $178K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.0% | 3,749 | 3,542 | $114K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.8% | 1,686 | 1,456 | $79K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 2.7% | 701 | 694 | $75K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.8% | 493 | 483 | $50K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 3,402 | 2,775 | $31K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 482 | 466 | $19K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,508 | 4,307 | $19K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,088 | 1,007 | $15K |
69 more codes
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,475 | $15K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 108 | $11K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 501 | $7K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 131 | $7K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 330 | $5K |
| 99442 | <1% | 175 | $4K | |
| 99001 | <1% | 4,260 | $3K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 31 | $3K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 100 | $3K |
| 83013 | <1% | 96 | $3K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 12 | $3K |
| 99401 | <1% | 171 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 131 | $2K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,415 | $2K |
| 99000 | <1% | 568 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 973 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 216 | $2K |
| 99441 | <1% | 78 | $1K | |
| 96127 | <1% | 426 | $1K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 12 | $1K |
| 90658 | <1% | 82 | $1K | |
| 81025 | <1% | 124 | $921.04 | |
| 99407 | <1% | 59 | $750.22 | |
| 81005 | <1% | 631 | $716.54 | |
| 96160 | <1% | 443 | $633.87 | |
| 81003 | <1% | 308 | $567.50 | |
| 93000 | <1% | 53 | $474.77 | |
| 87420 | <1% | 72 | $423.95 | |
| 86803 | <1% | 200 | $385.20 | |
| 81002 | <1% | 87 | $253.08 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 315 | $188.13 |
| 87299 | <1% | 12 | $133.30 | |
| 82947 | <1% | 35 | $114.20 | |
| 90715 | <1% | 59 | $41.85 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 17 | $24.49 |
| 82784 | <1% | 14 | $15.40 | |
| 86703 | <1% | 52 | $11.86 | |
| 3011F | <1% | 1,538 | $2.89 | |
| 3074F | <1% | 1,886 | $2.37 | |
| 3078F | <1% | 1,736 | $1.94 | |
| 1159F | <1% | 472 | $1.53 | |
| 98960 | <1% | 635 | $1.42 | |
| 3008F | <1% | 849 | $1.22 | |
| 3079F | <1% | 710 | $1.05 | |
| 3075F | <1% | 348 | $0.47 | |
| 3077F | <1% | 300 | $0.27 | |
| 1160F | <1% | 35 | $0.16 | |
| 3080F | <1% | 93 | $0.15 | |
| 1033F | <1% | 65 | $0.14 | |
| 4019F | <1% | 53 | $0.11 | |
| 90749 | <1% | 45 | $0.09 | |
| 3044F | <1% | 1,379 | $0.02 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 129 | $0.00 |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | 0% | 1,889 | $0.00 |
| 97802 | 0% | 149 | $0.00 | |
| 2000F | 0% | 139 | $0.00 | |
| M1296 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 25 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 599 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 186 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 100 | $0.00 |
| G9273 | Blood pressure has a systolic value of < 140 and a diastolic value of < 90 | 0% | 61 | $0.00 |
| G8421 | Bmi not documented and no reason is given | 0% | 79 | $0.00 |
| 90734 | 0% | 66 | $0.00 | |
| 3725F | 0% | 104 | $0.00 | |
| 99072 | 0% | 2,390 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 78 | $0.00 |
| 90461 | 0% | 119 | $0.00 | |
| 4004F | 0% | 51 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Mike Eldirani MD PLC | Dearborn, MI | $1.78M |
| My Clinic PLLC | Dearborn, MI | $1.09M |
| Get Well Urgent Care Taylor PLC | Taylor, MI | $870K |
| Wafa a Elhassan MD PLLC | Wayne, MI | $472K |
| MD 1ST PLLC | Flat Rock, MI | $386K |
| True Health Urgent Care PLLC | Farmington Hills, MI | $230K |
| Amine P Amine MD PC | Saint Clair Shores, MI | $138K |
| Livewell Medical Group PLLC | Hamtramck, MI | $137K |
| Family Urgent Care PLLC | Walled Lake, MI | $134K |
| Hasan Arrat PLLC | Dearborn, MI | $113K |
| M Saleem MD PC | Davison, MI | $36K |
| Primary Care Associates Group PC | Saint Clair Shores, MI | $14K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.